AgelessRx, a leading telehealth platform specializing in longevity, has expanded its services to include sleep health. Recognizing the crucial role of sleep in overall well-being and longevity, the company now offers personalized sleep treatment plans incorporating lifestyle recommendations, prescription medication, and over-the-counter supplements. This expansion builds upon AgelessRx’s commitment to proactive healthcare and redefining aging.

The new sleep program emphasizes a research-backed approach, tailoring solutions to individual needs and integrating them into holistic treatment plans focused on extending lifespan and healthspan. Understanding that insufficient sleep undermines the benefits of diet and exercise, AgelessRx aims to make quality sleep a central component of everyone’s longevity routine.

Poor sleep is a widespread problem, affecting one in three Americans, and is often exacerbated by the demands of modern life. It significantly increases the risk of chronic diseases like heart disease, diabetes, and obesity, all of which are linked to shorter lifespans. AgelessRx seeks to address this growing health crisis by offering practical and effective solutions.

The company’s new sleep offerings include Trazodone, a prescription sleep aid, and Tran-Q Sleep, a natural, melatonin-free, over-the-counter supplement. Both are non-habit forming and support the four key pillars of healthy sleep: quantity, quality, regularity, and timing. AgelessRx’s clinical team thoroughly reviews each patient’s medical history, needs, and goals to determine the most suitable treatment. These options cater to a wide range of individual sleep needs and aim to improve overall sleep architecture – the cyclical progression through different sleep stages.

Source link: http://www.businesswire.com/news/home/20241119554839/en/AgelessRx-Enters-Sleep-Health-Category-Underscoring-Critical-Role-Sleep-Plays-in-Healthspan-and-Lifespan

+ posts

Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.